Apigenin as an anticancer agent

Phytotherapy Research

Volumn 34, Issue 8, 2020, Pages 1812-1828

  Imran, Muhammad ^a   Aslam Gondal, Tanweer ^b   Atif, Muhammad ^c   Shahbaz, Muhammad ^d   Batool Qaisarani, Tahira ^e   Hanif Mughal, Muhammad ^a   Salehi, Bahare ^f   Martorell, Miquel ^g   Sharifi Rad, Javad ^h  

^a UNIVERSITY OF LAHORE   (Pakistan)

^b DEAKIN UNIVERSITY   (Australia)

^c JOUF UNIVERSITY   (Saudi Arabia)

^d MNS UNIVERSITY OF AGRICULTURE   (Pakistan)

^e Ghazi University   (Pakistan)

^f BAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g UNIVERSITY OF CONCEPCIÓN   (Chile)

^h SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

apigenin; breast cancer; flavonoids; glioblastoma; liver cancer; pancreatic cancer; prostate cancer

Indexed keywords

APIGENIN; CASPASE 3; CASPASE 8; CISPLATIN; CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYTOCHROME C; DOCETAXEL; FLUOROURACIL; GELATINASE A; GELATINASE B; GELDANAMYCIN; GEMCITABINE; IRINOTECAN; NAVITOCLAX; NUCLEAR FACTOR KAPPA B P105; OCTAMER TRANSCRIPTION FACTOR 4; OXALIPLATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VEMURAFENIB; VORINOSTAT; ANTINEOPLASTIC AGENT;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AUTOPHAGY (CELLULAR); AUTOPHOSPHORYLATION; BINDING AFFINITY; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER INHIBITION; CELL ADHESION; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SELF-RENEWAL; CELL SURVIVAL; CELL VIABILITY; COLON CANCER; COLORECTAL CANCER; DOWN REGULATION; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE KNOCKDOWN; GENE OVEREXPRESSION; GENE TRANSLOCATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LARYNX CARCINOMA; LEUKEMIA; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; METASTASIS; METASTASIS INHIBITION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUTH CANCER; MTOR SIGNALING; NEUROBLASTOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PI3K AKT NF KB SIGNALING PATHWAY; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; STOMACH CANCER; UBIQUITINATION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING; WNT NBETA CATENIN SIGNALING PATHWAY; CHEMISTRY; FEMALE; MALE; NEOPLASM; PLANT;

ANTICARCINOGENIC AGENTS; APIGENIN; FEMALE; HUMANS; MALE; NEOPLASMS; PLANTS;

EID: 85079460036     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.6647     Document Type: Review

References (149)

1. Babcook, M. A., & Gupta, S. (2012). Apigenin modulates insulin-like growth factor axis: Implications for prevention and therapy of prostate cancer. Current Drug Targets, Advance online publication.
2. Bai, H., Jin, H., Yang, F., Zhu, H., & Cai, J. (2014). Apigenin induced MCF-7 cell apoptosis-associated reactive oxygen species. Scanning, 36(6), 622–631. https://doi.org/10.1002/sca.21170
3. Banerjee, K., & Mandal, M. (2015). Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells. Redox Biology, 5, 153–162. https://doi.org/10.1016/j.redox.2015.04.009
4. Bao, Y. Y., Zhou, S. H., Lu, Z. J., Fan, J., & Huang, Y. P. (2015). Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo. Oncology Reports, 34(4), 1805–1814. https://doi.org/10.3892/or.2015.4158
5. Bauer, D., Mazzio, E., & Soliman, K. F. A. (2019). Whole Transcriptomic analysis of Apigenin on TNFα Immuno-activated MDA-MB-231 breast cancer cells. Cancer Genomics & Proteomics, 16(6), 421–431. https://doi.org/10.21873/cgp.20146
6. Bridgeman, B. B., Wang, P., Ye, B., Pelling, J. C., Volpert, O. V., & Tong, X. (2016). Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention. Cellular Signalling, 28(5), 460–468. https://doi.org/10.1016/j.cellsig.2016.02.008
7. Bruno, A., Siena, L., Gerbino, S., Ferraro, M., Chanez, P., Giammanco, M., … Pace, E. (2011). Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell line. European Journal of Cancer, 47(13), 2042–2051. https://doi.org/10.1016/j.ejca.2011.03.034
8. Budhraja, A., Gao, N., Zhang, Z., Son, Y. O., Cheng, S., Wang, X., … Shi, X. (2012). Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Molecular Cancer Therapeutics, 11(1), 132–142. https://doi.org/10.1158/1535-7163.mct-11-0343
9. Cai, J., Zhao, X. L., Liu, A. W., Nian, H., & Zhang, S. H. (2011). Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns. Phytomedicine, 18(5), 366–373. https://doi.org/10.1016/j.phymed.2010.08.006
10. Cao, X., Liu, B., Cao, W., Zhang, W., Zhang, F., Zhao, H., … Zhang, B. (2013). Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells. Chinese Journal of Cancer Research, 25(2), 212–222. https://doi.org/10.3978/j.issn.1000-9604.2013.04.01
11. Cardenas, H., Arango, D., Nicholas, C., Duarte, S., Nuovo, G. J., He, W., … Doseff, A. I. (2016). Dietary Apigenin exerts immune-regulatory activity in vivo by reducing NF-kappaB activity, halting leukocyte infiltration and restoring Normal metabolic function. International Journal of Molecular Sciences, 17(3), 323. https://doi.org/10.3390/ijms17030323
12. Chakrabarti, M., Banik, N. L., & Ray, S. K. (2013). Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells. Journal of Molecular Neuroscience, 51(1), 187–198. https://doi.org/10.1007/s12031-013-9975-x
13. Chan, L. P., Chou, T. H., Ding, H. Y., Chen, P. R., Chiang, F. Y., Kuo, P. L., & Liang, C. H. (2012). Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. Biochimica et Biophysica Acta, 1820(7), 1081–1091. https://doi.org/10.1016/j.bbagen.2012.04.013
14. Chang, J.-H., Cheng, C.-W., Yang, Y.-C., Chen, W.-S., Hung, W.-Y., Chow, J.-M., … Chien, M.-H. (2018). Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and snail/slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses. Journal of Experimental & Clinical Cancer Research, 37(1), 199–199. https://doi.org/10.1186/s13046-018-0869-1
15. Chen, D., Landis-Piwowar, K. R., Chen, M. S., & Dou, Q. P. (2007). Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Research, 9(6), R80.
16. Chen, J., Chen, J., Li, Z., Liu, C., & Yin, L. (2014). The apoptotic effect of apigenin on human gastric carcinoma cells through mitochondrial signal pathway. Tumour Biology, 35(8), 7719–7726. https://doi.org/10.1007/s13277-014-2014-x
17. Chen, M., Wang, X., Zha, D., Cai, F., Zhang, W., He, Y., … Hua, Z. C. (2016). Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner. Scientific Reports, 6, 35468. https://doi.org/10.1038/srep35468
18. Chen, V., Staub, R. E., Baggett, S., Chimmani, R., Tagliaferri, M., Cohen, I., & Shtivelman, E. (2012). Identification and analysis of the active phytochemicals from the anti-cancer botanical extract Bezielle. PLoS One, 7(1), e30107. https://doi.org/10.1371/journal.pone.0030107
19. Chen, W. Y., Hsieh, Y. A., Tsai, C. I., Kang, Y. F., Chang, F. R., Wu, Y. C., & Wu, C. C. (2011). Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase pi. Investigational New Drugs, 29(6), 1347–1359. https://doi.org/10.1007/s10637-010-9497-0
20. Chen, X., Xu, H., Yu, X., Wang, X., Zhu, X., & Xu, X. (2019). Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway. Journal of BUON, 24(2), 488–493.
21. Chiang, L. C., Ng, L. T., Lin, I. C., Kuo, P. L., & Lin, C. C. (2006). Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells. Cancer Letters, 237(2), 207–214. https://doi.org/10.1016/j.canlet.2005.06.002
22. Choi, S. I., Jeong, C. S., Cho, S. Y., & Lee, Y. S. (2007). Mechanism of apoptosis induced by apigenin in HepG2 human hepatoma cells: Involvement of reactive oxygen species generated by NADPH oxidase. Archives of Pharmacal Research, 30(10), 1328–1335.
23. Choudhury, D., Ganguli, A., Dastidar, D. G., Acharya, B. R., Das, A., & Chakrabarti, G. (2013). Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin. Biochimie, 95(6), 1297–1309. https://doi.org/10.1016/j.biochi.2013.02.010
24. Chung, C. S., Jiang, Y., Cheng, D., & Birt, D. F. (2007). Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin. Molecular Carcinogenesis, 46(9), 773–782. https://doi.org/10.1002/mc.20306
25. Chunhua, L., Donglan, L., Xiuqiong, F., Lihua, Z., Qin, F., Yawei, L., … Xuegang, S. (2013). Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT. The Journal of Nutritional Biochemistry, 24(10), 1766–1775. https://doi.org/10.1016/j.jnutbio.2013.03.006
26. Coombs, M. R., Harrison, M. E., & Hoskin, D. W. (2016). Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells. Cancer Letters, 380(2), 424–433. https://doi.org/10.1016/j.canlet.2016.06.023
27. Crespo, I., Garcia-Mediavilla, M. V., Almar, M., Gonzalez, P., Tunon, M. J., Sanchez-Campos, S., & Gonzalez-Gallego, J. (2008). Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang liver cells. Food and Chemical Toxicology, 46(5), 1555–1569. https://doi.org/10.1016/j.fct.2007.12.014
28. Czernik, M., Sroka, J., Madeja, Z., & Czyz, J. (2008). Apigenin inhibits growth and motility but increases gap junctional coupling intensity in rat prostate carcinoma (MAT-LyLu) cell populations. Cellular & Molecular Biology Letters, 13(3), 327–338. https://doi.org/10.2478/s11658-008-0003-z
29. Dai, J., Van Wie, P. G., Fai, L. Y., Kim, D., Wang, L., Poyil, P., … Zhang, Z. (2016). Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells. Toxicology and Applied Pharmacology, 311, 106–112. https://doi.org/10.1016/j.taap.2016.09.016
30. Das, A., Banik, N. L., & Ray, S. K. (2010). Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer, 116(1), 164–176. https://doi.org/10.1002/cncr.24699
31. Das, S., Das, J., Samadder, A., Boujedaini, N., & Khuda-Bukhsh, A. R. (2012). Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria. Experimental Biology and Medicine (Maywood, N.J.), 237(12), 1433–1448. https://doi.org/10.1258/ebm.2012.012148
32. Das, S., Das, J., Samadder, A., Paul, A., & Khuda-Bukhsh, A. R. (2013). Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: Mitochondria mediated apoptotic signalling cascades. Food and Chemical Toxicology, 62, 670–680. https://doi.org/10.1016/j.fct.2013.09.037
33. Erdogan, S., Doganlar, O., Doganlar, Z. B., Serttas, R., Turkekul, K., Dibirdik, I., & Bilir, A. (2016). The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-kappaB signaling. Life Sciences, 162, 77–86. https://doi.org/10.1016/j.lfs.2016.08.019
34. Erdogan, S., Turkekul, K., Dibirdik, I., Doganlar, Z. B., Doganlar, O., & Bilir, A. (2019). Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: Cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB. Investigational New Drugs. https://doi.org/10.1007/s10637-019-00774-8
35. Erdogan, S., Turkekul, K., Serttas, R., & Erdogan, Z. (2017). The natural flavonoid apigenin sensitizes human CD44(+) prostate cancer stem cells to cisplatin therapy. Biomedicine & Pharmacotherapy, 88, 210–217. https://doi.org/10.1016/j.biopha.2017.01.056
36. Fang, J., Zhou, Q., Liu, L. Z., Xia, C., Hu, X., Shi, X., & Jiang, B. H. (2007). Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis, 28(4), 858–864. https://doi.org/10.1093/carcin/bgl205
37. Franzen, C. A., Amargo, E., Todorovic, V., Desai, B. V., Huda, S., Mirzoeva, S., … Pelling, J. C. (2009). The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prevention Research (Philadelphia, Pa.), 2(9), 830–841. https://doi.org/10.1158/1940-6207.capr-09-0066
38. Ganai, S. A. (2017). Plant-derived flavone Apigenin: The small-molecule with promising activity against therapeutically resistant prostate cancer. Biomedicine & Pharmacotherapy, 85, 47–56. https://doi.org/10.1016/j.biopha.2016.11.130
39. Gao, A. M., Ke, Z. P., Wang, J. N., Yang, J. Y., Chen, S. Y., & Chen, H. (2013). Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway. Carcinogenesis, 34(8), 1806–1814. https://doi.org/10.1093/carcin/bgt108
40. Ghițu, A., Schwiebs, A., Radeke, H. H., Avram, S., Zupko, I., Bor, A., … Danciu, C. (2019). A comprehensive assessment of Apigenin as an antiproliferative, proapoptotic, antiangiogenic and immunomodulatory phytocompound. Nutrients, 11(4), 858. https://doi.org/10.3390/nu11040858
41. Gilardini Montani, M. S., Cecere, N., Granato, M., Romeo, M. A., Falcinelli, L., Ciciarelli, U., … Cirone, M. (2019). Mutant p53, stabilized by its interplay with HSP90, activates a positive feed-Back loop between NRF2 and p62 that induces chemo-resistance to Apigenin in pancreatic cancer cells. Cancers, 11(5), 703. https://doi.org/10.3390/cancers11050703
42. Gomez-Garcia, F. J., Lopez-Jornet, M. P., Alvarez-Sanchez, N., Castillo-Sanchez, J., Benavente-Garcia, O., & Vicente Ortega, V. (2013). Effect of the phenolic compounds apigenin and carnosic acid on oral carcinogenesis in hamster induced by DMBA. Oral Diseases, 19(3), 279–286. https://doi.org/10.1111/j.1601-0825.2012.01975.x
43. Gonzalez-Mejia, M. E., Voss, O. H., Murnan, E. J., & Doseff, A. I. (2010). Apigenin-induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein-27. Cell Death & Disease, 1, e64. https://doi.org/10.1038/cddis.2010.41
44. Guo, H., Kong, S., Chen, W., Dai, Z., Lin, T., Su, J., … Lai, X. (2014). Apigenin mediated protection of OGD-evoked neuron-like injury in differentiated PC12 cells. Neurochemical Research, 39(11), 2197–2210. https://doi.org/10.1007/s11064-014-1421-0
45. Ha, S. K., Lee, P., Park, J. A., Oh, H. R., Lee, S. Y., Park, J. H., … Kim, S. Y. (2008). Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochemistry International, 52(4–5), 878–886. https://doi.org/10.1016/j.neuint.2007.10.005
46. Harrison, M. E., Power Coombs, M. R., Delaney, L. M., & Hoskin, D. W. (2014). Exposure of breast cancer cells to a subcytotoxic dose of apigenin causes growth inhibition, oxidative stress, and hypophosphorylation of Akt. Experimental and Molecular Pathology, 97(2), 211–217. https://doi.org/10.1016/j.yexmp.2014.07.006
47. Hashemi, M., Nouri Long, M., Entezari, M., Nafisi, S., & Nowroozii, H. (2010). Anti-mutagenic and pro-apoptotic effects of apigenin on human chronic lymphocytic leukemia cells. Acta Medica Iranica, 48(5), 283–288.
48. He, J., Xu, Q., Wang, M., Li, C., Qian, X., Shi, Z., … Jiang, B. H. (2012). Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model. International Journal of Molecular Sciences, 13(6), 7271–7282. https://doi.org/10.3390/ijms13067271
49. Hu, X. W., Meng, D., & Fang, J. (2008). Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis, 29(12), 2369–2376. https://doi.org/10.1093/carcin/bgn244
50. Hu, X. Y., Liang, J. Y., Guo, X. J., Liu, L., & Guo, Y. B. (2015). 5-fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (DeltaPsim)-mediated apoptosis in hepatocellular carcinoma. Clinical and Experimental Pharmacology & Physiology, 42(2), 146–153. https://doi.org/10.1111/1440-1681.12333
51. Huang, C., Wei, Y. X., Shen, M. C., Tu, Y. H., Wang, C. C., & Huang, H. C. (2016). Chrysin, abundant in Morinda citrifolia fruit water-EtOAc extracts, combined with Apigenin synergistically induced apoptosis and inhibited migration in human breast and liver cancer cells. Journal of Agricultural and Food Chemistry, 64(21), 4235–4245. https://doi.org/10.1021/acs.jafc.6b00766
52. Hwang, Y. P., Oh, K. N., Yun, H. J., & Jeong, H. G. (2011). The flavonoids apigenin and luteolin suppress ultraviolet A-induced matrix metalloproteinase-1 expression via MAPKs and AP-1-dependent signaling in HaCaT cells. Journal of Dermatological Science, 61(1), 23–31. https://doi.org/10.1016/j.jdermsci.2010.10.016
53. Ittiudomrak, T., Puthong, S., Roytrakul, S., & Chanchao, C. (2019). α-Mangostin and Apigenin induced cell cycle arrest and programmed cell death in SKOV-3 ovarian cancer cells. Toxicological Research, 35(2), 167–179. https://doi.org/10.5487/TR.2019.35.2.167
54. Jangdey, M. S., Gupta, A., Saraf, S., & Saraf, S. (2017). Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation. Artif Cells Nanomed Biotechnol, 45(7), 1452–1462. https://doi.org/10.1080/21691401.2016.1247850
55. Jayasooriya, R. G., Kang, S. H., Kang, C. H., Choi, Y. H., Moon, D. O., Hyun, J. W., … Kim, G. Y. (2012). Apigenin decreases cell viability and telomerase activity in human leukemia cell lines. Food and Chemical Toxicology, 50(8), 2605–2611. https://doi.org/10.1016/j.fct.2012.05.024
56. Jeyabal, P. V., Syed, M. B., Venkataraman, M., Sambandham, J. K., & Sakthisekaran, D. (2005). Apigenin inhibits oxidative stress-induced macromolecular damage in N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinogenesis in Wistar albino rats. Molecular Carcinogenesis, 44(1), 11–20. https://doi.org/10.1002/mc.20115
57. Johnson, J. L., & de Mejia, E. G. (2013). Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3beta/NF-kappaB signaling cascade. Molecular Nutrition & Food Research, 57(12), 2112–2127. https://doi.org/10.1002/mnfr.201300307
58. Johnson, J. L., & Gonzalez de Mejia, E. (2013). Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro. Food and Chemical Toxicology, 60, 83–91. https://doi.org/10.1016/j.fct.2013.07.036
59. Johnson, J. L., Rupasinghe, S. G., Stefani, F., Schuler, M. A., & Gonzalez de Mejia, E. (2011). Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3beta enzymatic activity by lowering the interaction energy within the binding cavity. Journal of Medicinal Food, 14(4), 325–333. https://doi.org/10.1089/jmf.2010.0310
60. Kanerva, A., Raki, M., Ranki, T., Sarkioja, M., Koponen, J., Desmond, R. A., … Hemminki, A. (2007). Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity. The Journal of Gene Medicine, 9(1), 3–9. https://doi.org/10.1002/jgm.984
61. Kaur, P., Shukla, S., & Gupta, S. (2008). Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: An in vitro and in vivo study. Carcinogenesis, 29(11), 2210–2217. https://doi.org/10.1093/carcin/bgn201
62. Ketkaew, Y., Osathanon, T., Pavasant, P., & Sooampon, S. (2017). Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line. Archives of Oral Biology, 74, 69–74. https://doi.org/10.1016/j.archoralbio.2016.11.010
63. Kim, B., Jung, N., Lee, S., Sohng, J. K., & Jung, H. J. (2016). Apigenin inhibits cancer stem cell-like phenotypes in human Glioblastoma cells via suppression of c-met signaling. Phytotherapy Research, 30(11), 1833–1840. https://doi.org/10.1002/ptr.5689
64. Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S. H., Choi, M. G., Yoo, H. J., & Lee, S. J. (2013a). Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E. Journal of Endocrinological Investigation, 36(11), 1099–1104. https://doi.org/10.3275/9099
65. Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S. H., Choi, M. G., Yoo, H. J., & Lee, S. J. (2013b). Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells. Molecular and Cellular Endocrinology, 369(1–2), 130–139. https://doi.org/10.1016/j.mce.2013.01.012
66. King, J. C., Lu, Q. Y., Li, G., Moro, A., Takahashi, H., Chen, M., … Hines, O. J. (2012). Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. Biochimica et Biophysica Acta, 1823(2), 593–604. https://doi.org/10.1016/j.bbamcr.2011.12.008
67. Kiraly, A. J., Soliman, E., Jenkins, A., & Van Dross, R. T. (2016). Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 104, 44–53. https://doi.org/10.1016/j.plefa.2015.11.006
68. Kuo, C. H., Weng, B. C., Wu, C. C., Yang, S. F., Wu, D. C., & Wang, Y. C. (2014). Apigenin has anti-atrophic gastritis and anti-gastric cancer progression effects in helicobacter pylori-infected Mongolian gerbils. Journal of Ethnopharmacology, 151(3), 1031–1039. https://doi.org/10.1016/j.jep.2013.11.040
69. Lakshmanan, A., Doseff, A. I., Ringel, M. D., Saji, M., Rousset, B., Zhang, X., & Jhiang, S. M. (2014). Apigenin in combination with Akt inhibition significantly enhances thyrotropin-stimulated radioiodide accumulation in thyroid cells. Thyroid, 24(5), 878–887. https://doi.org/10.1089/thy.2013.0614
70. Lecomte, S., Demay, F., Pham, T. H., Moulis, S., Efstathiou, T., Chalmel, F., & Pakdel, F. (2019). Deciphering the molecular mechanisms sustaining the estrogenic activity of the two major dietary compounds Zearalenone and Apigenin in ER-positive breast cancer cell lines. Nutrients, 11(2), 237. https://doi.org/10.3390/nu11020237
71. Lee, H. H., Jung, J., Moon, A., Kang, H., & Cho, H. (2019). Antitumor and anti-invasive effect of Apigenin on human breast carcinoma through suppression of IL-6 expression. International Journal of Molecular Sciences, 20(13), 3143. https://doi.org/10.3390/ijms20133143
72. Lee, S. H., Ryu, J. K., Lee, K. Y., Woo, S. M., Park, J. K., Yoo, J. W., … Yoon, Y. B. (2008). Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Letters, 259(1), 39–49. https://doi.org/10.1016/j.canlet.2007.09.015
73. Lee, S. W., Lee, J. T., Lee, M. G., Lee, H. W., Ahn, S. J., Lee, Y. J., … Ha, J. H. (2009). In vitro antiproliferative characteristics of flavonoids and diazepam on SNU-C4 colorectal adenocarcinoma cells. Journal of Natural Medicines, 63(2), 124–129. https://doi.org/10.1007/s11418-008-0300-x
74. Lee, Y., Sung, B., Kang, Y. J., Kim, D. H., Jang, J. Y., Hwang, S. Y., … Kim, N. D. (2014). Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells. International Journal of Oncology, 44(5), 1599–1606. https://doi.org/10.3892/ijo.2014.2339
75. Lee, Y. M., Lee, G., Oh, T. I., Kim, B. M., Shim, D. W., Lee, K. H., … Lim, J. H. (2016). Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress. International Journal of Oncology, 48(1), 399–408. https://doi.org/10.3892/ijo.2015.3243
76. Lefort, E. C., & Blay, J. (2011). The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells. Clinical & Experimental Metastasis, 28(4), 337–349. https://doi.org/10.1007/s10585-010-9364-6
77. Leonardi, T., Vanamala, J., Taddeo, S. S., Davidson, L. A., Murphy, M. E., Patil, B. S., … Turner, N. D. (2010). Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Experimental Biology and Medicine (Maywood, N.J.), 235(6), 710–717. https://doi.org/10.1258/ebm.2010.009359
78. Li, S., Yang, L. J., Wang, P., He, Y. J., Huang, J. M., Liu, H. W., … Wang, F. (2016). Dietary apigenin potentiates the inhibitory effect of interferon-alpha on cancer cell viability through inhibition of 26S proteasome-mediated interferon receptor degradation. Food & Nutrition Research, 60, 31288. https://doi.org/10.3402/fnr.v60.31288
79. Li, Y., Cheng, X., Chen, C., Huijuan, W., Zhao, H., Liu, W., … Wang, Q. (2019). Apigenin, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1/CDK4 regulation via p38 MAPK-p21 signaling. Pathology - Research and Practice, 216(1), 152701. https://doi.org/10.1016/j.prp.2019.152701
80. Li, Z. D., Hu, X. W., Wang, Y. T., & Fang, J. (2009). Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1. FEBS Letters, 583(12), 1999–2003. https://doi.org/10.1016/j.febslet.2009.05.013
81. Lin, C. C., Chuang, Y. J., Yu, C. C., Yang, J. S., Lu, C. C., Chiang, J. H., … Chung, J. G. (2012). Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo. Journal of Agricultural and Food Chemistry, 60(45), 11395–11402. https://doi.org/10.1021/jf303446x
82. Liu, J., Cao, X. C., Xiao, Q., & Quan, M. F. (2015). Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2alpha. Molecular Medicine Reports, 11(1), 665–669. https://doi.org/10.3892/mmr.2014.2720
83. Liu, X., Li, L., Lv, L., Chen, D., Shen, L., & Xie, Z. (2015). Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/beta-catenin signaling pathway. Oncology Reports, 34(2), 1035–1041. https://doi.org/10.3892/or.2015.4022
84. Lu, H. F., Chie, Y. J., Yang, M. S., Lee, C. S., Fu, J. J., Yang, J. S., … Chung, J. G. (2010). Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway. International Journal of Oncology, 36(6), 1477–1484. https://doi.org/10.3892/ijo_00000634
85. Lu, H. F., Chie, Y. J., Yang, M. S., Lu, K. W., Fu, J. J., Yang, J. S., … Chung, J. G. (2011). Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathways. Human & Experimental Toxicology, 30(8), 1053–1061. https://doi.org/10.1177/0960327110386258
86. Maeda, Y., Takahashi, H., Nakai, N., Yanagita, T., Ando, N., Okubo, T., … Takiguchi, S. (2018). Apigenin induces apoptosis by suppressing Bcl-xl and mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer. International Journal of Oncology, 52, 1661–1673. https://doi.org/10.3892/ijo.2018.4308
87. Mafuvadze, B., Benakanakere, I., & Hyder, S. M. (2010). Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells. Menopause, 17(5), 1055–1063. https://doi.org/10.1097/gme.0b013e3181dd052f
88. Mafuvadze, B., Benakanakere, I., Lopez Perez, F. R., Besch-Williford, C., Ellersieck, M. R., & Hyder, S. M. (2011). Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Cancer Prevention Research (Philadelphia, Pa.), 4(8), 1316–1324. https://doi.org/10.1158/1940-6207.capr-10-0382
89. Mafuvadze, B., Cook, M., Xu, Z., Besch-Williford, C. L., & Hyder, S. M. (2013). Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model. Nutrition and Cancer, 65(8), 1184–1191. https://doi.org/10.1080/01635581.2013.833637
90. Maggioni, D., Garavello, W., Rigolio, R., Pignataro, L., Gaini, R., & Nicolini, G. (2013). Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis. International Journal of Oncology, 43(5), 1675–1682. https://doi.org/10.3892/ijo.2013.2072
91. Masuelli, L., Marzocchella, L., Quaranta, A., Palumbo, C., Pompa, G., Izzi, V., … Bei, R. (2011). Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling. Front Biosci (Landmark Ed), 16, 1060–1068.
92. Melstrom, L. G., Salabat, M. R., Ding, X. Z., Strouch, M. J., Grippo, P. J., Mirzoeva, S., … Bentrem, D. J. (2011). Apigenin down-regulates the hypoxia response genes: HIF-1alpha, GLUT-1, and VEGF in human pancreatic cancer cells. The Journal of Surgical Research, 167(2), 173–181. https://doi.org/10.1016/j.jss.2010.10.041
93. Mirzoeva, S., Franzen, C. A., & Pelling, J. C. (2014). Apigenin inhibits TGF-beta-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism. Molecular Carcinogenesis, 53(8), 598–609. https://doi.org/10.1002/mc.22005
94. Mirzoeva, S., Tong, X., Bridgeman, B. B., Plebanek, M. P., & Volpert, O. V. (2018). Apigenin inhibits UVB-induced skin carcinogenesis: The role of Thrombospondin-1 as an anti-inflammatory factor. Neoplasia (New York, N.Y.), 20(9), 930–942. https://doi.org/10.1016/j.neo.2018.07.005
95. Mrazek, A. A., Porro, L. J., Bhatia, V., Falzon, M., Spratt, H., Zhou, J., … Hellmich, M. R. (2015). Apigenin inhibits pancreatic stellate cell activity in pancreatitis. The Journal of Surgical Research, 196(1), 8–16. https://doi.org/10.1016/j.jss.2015.02.032
96. Nakazaki, E., Tsolmon, S., Han, J., & Isoda, H. (2013). Proteomic study of granulocytic differentiation induced by apigenin 7-glucoside in human promyelocytic leukemia HL-60 cells. European Journal of Nutrition, 52(1), 25–35. https://doi.org/10.1007/s00394-011-0282-4
97. Nelson, N., Szekeres, K., Iclozan, C., Rivera, I. O., McGill, A., Johnson, G., … Ghansah, T. (2017). Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer. PLoS One, 12(2), e0170197. https://doi.org/10.1371/journal.pone.0170197
98. Oishi, M., Iizumi, Y., Taniguchi, T., Goi, W., Miki, T., & Sakai, T. (2013). Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2. PLoS One, 8(2), e55922. https://doi.org/10.1371/journal.pone.0055922
99. Pan, X., Yang, Z., Yang, Z., Zhou, S., Zhang, H., & Zang, L. (2013). Effect of apigenin on proliferation and apoptosis of human lung cancer NCI-H460 cells. Nan Fang Yi Ke Da Xue Xue Bao, 33(8), 1137–1140.
100. Pandey, M., Kaur, P., Shukla, S., Abbas, A., Fu, P., & Gupta, S. (2012). Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study. Molecular Carcinogenesis, 51(12), 952–962. https://doi.org/10.1002/mc.20866
101. Paredes-Gonzalez, X., Fuentes, F., Su, Z. Y., & Kong, A. N. (2014). Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications. The AAPS Journal, 16(4), 727–735. https://doi.org/10.1208/s12248-014-9613-8
102. Pham, H., Chen, M., Takahashi, H., King, J., Reber, H. A., Hines, O. J., … Eibl, G. (2012). Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells. Pancreas, 41(8), 1306–1315. https://doi.org/10.1097/MPA.0b013e31824d64d9
103. Ren, H. Y., & Tang, X. W. (2011). Anti-proliferation and chemo-sensitization effects of apigenin on human lung cancer cells. Zhejiang Da Xue Xue Bao. Yi Xue Ban, 40(5), 508–514.
104. Ruela-de-Sousa, R. R., Fuhler, G. M., Blom, N., Ferreira, C. V., Aoyama, H., & Peppelenbosch, M. P. (2010). Cytotoxicity of apigenin on leukemia cell lines: Implications for prevention and therapy. Cell Death & Disease, 1, e19. https://doi.org/10.1038/cddis.2009.18
105. Salabat, M. R., Melstrom, L. G., Strouch, M. J., Ding, X. Z., Milam, B. M., Ujiki, M. B., … Bentrem, D. J. (2008). Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines. Molecular Carcinogenesis, 47(11), 835–844. https://doi.org/10.1002/mc.20441
106. Salehi, B., Venditti, A., Sharifi-Rad, M., Kręgiel, D., Sharifi-Rad, J., Durazzo, A., … Martins, N. (2019). The therapeutic potential of Apigenin. International Journal of Molecular Sciences, 20(6), 1305. https://doi.org/10.3390/ijms20061305
107. Seo, H. S., Choi, H. S., Kim, S. R., Choi, Y. K., Woo, S. M., Shin, I., … Ko, S. G. (2012). Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFkappaB signaling in HER2-overexpressing breast cancer cells. Molecular and Cellular Biochemistry, 366(1–2), 319–334. https://doi.org/10.1007/s11010-012-1310-2
108. Seo, H. S., Ku, J. M., Choi, H. S., Woo, J. K., Jang, B. H., Go, H., … Ko, S. G. (2015). Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells. Molecular Medicine Reports, 12(2), 2977–2984. https://doi.org/10.3892/mmr.2015.3698
109. Seo, Y. J., Kim, B. S., Chun, S. Y., Park, Y. K., Kang, K. S., & Kwon, T. G. (2011). Apoptotic effects of genistein, biochanin-a and apigenin on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1. Journal of Korean Medical Science, 26(11), 1489–1494. https://doi.org/10.3346/jkms.2011.26.11.1489
110. Shao, H., Jing, K., Mahmoud, E., Huang, H., Fang, X., & Yu, C. (2013). Apigenin sensitizes colon cancer cells to antitumor activity of ABT-263. Molecular Cancer Therapeutics, 12(12), 2640–2650. https://doi.org/10.1158/1535-7163.mct-13-0066
111. Shukla, S., Bhaskaran, N., Babcook, M. A., Fu, P., Maclennan, G. T., & Gupta, S. (2014). Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis, 35(2), 452–460. https://doi.org/10.1093/carcin/bgt316
112. Shukla, S., & Gupta, S. (2007). Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle, 6(9), 1102–1114. https://doi.org/10.4161/cc.6.9.4146
113. Shukla, S., & Gupta, S. (2008). Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radical Biology & Medicine, 44(10), 1833–1845. https://doi.org/10.1016/j.freeradbiomed.2008.02.007
114. Shukla, S., & Gupta, S. (2009). Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study. Molecular Carcinogenesis, 48(3), 243–252. https://doi.org/10.1002/mc.20475
115. Shukla, S., & Gupta, S. (2010). Apigenin: A promising molecule for cancer prevention. Pharmaceutical Research, 27(6), 962–978. https://doi.org/10.1007/s11095-010-0089-7
116. Shukla, S., Kanwal, R., Shankar, E., Datt, M., Chance, M. R., Fu, P., … Gupta, S. (2015). Apigenin blocks IKKalpha activation and suppresses prostate cancer progression. Oncotarget, 6(31), 31216–31232. https://doi.org/10.18632/oncotarget.5157
117. Silvan, S., & Manoharan, S. (2013). Apigenin prevents deregulation in the expression pattern of cell-proliferative, apoptotic, inflammatory and angiogenic markers during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Archives of Oral Biology, 58(1), 94–101. https://doi.org/10.1016/j.archoralbio.2012.06.005
118. Silvan, S., Manoharan, S., Baskaran, N., Anusuya, C., Karthikeyan, S., & Prabhakar, M. M. (2011). Chemopreventive potential of apigenin in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis. European Journal of Pharmacology, 670(2–3), 571–577. https://doi.org/10.1016/j.ejphar.2011.09.179
119. Singh, J. P., Selvendiran, K., Banu, S. M., Padmavathi, R., & Sakthisekaran, D. (2004). Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats. Phytomedicine, 11(4), 309–314.
120. Singh, V., Sharma, V., Verma, V., Pandey, D., Yadav, S. K., Maikhuri, J. P., & Gupta, G. (2015). Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-beta from degradation and induce apoptosis in prostate cancer cells. European Journal of Nutrition, 54(8), 1255–1267. https://doi.org/10.1007/s00394-014-0803-z
121. Solmaz, S., Adan Gokbulut, A., Cincin, B., Ozdogu, H., Boga, C., Cakmakoglu, B., … Baran, Y. (2014). Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells. Nutrition and Cancer, 66(4), 599–612. https://doi.org/10.1080/01635581.2014.894099
122. Souza, R. P., Bonfim-Mendonca, P. S., Gimenes, F., Ratti, B. A., Kaplum, V., Bruschi, M. L., … Consolaro, M. E. (2017). Oxidative stress triggered by Apigenin induces apoptosis in a comprehensive panel of human cervical cancer-derived cell lines. Oxidative Medicine and Cellular Longevity, 2017, 1512745–1512718. https://doi.org/10.1155/2017/1512745
123. Strouch, M. J., Milam, B. M., Melstrom, L. G., McGill, J. J., Salabat, M. R., Ujiki, M. B., … Bentrem, D. J. (2009). The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. Pancreas, 38(4), 409–415. https://doi.org/10.1097/MPA.0b013e318193a074
124. Suh, Y. A., Jo, S. Y., Lee, H. Y., & Lee, C. (2015). Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells. International Journal of Oncology, 46(3), 1405–1411. https://doi.org/10.3892/ijo.2014.2808
125. Swanson, H. I., Choi, E. Y., Helton, W. B., Gairola, C. G., & Valentino, J. (2014). Impact of apigenin and kaempferol on human head and neck squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 117(2), 214–220. https://doi.org/10.1016/j.oooo.2013.10.012
126. Tang, A. Q., Cao, X. C., Tian, L., He, L., & Liu, F. (2015). Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3derived sphere-forming cells. Molecular Medicine Reports, 11(3), 2221–2226. https://doi.org/10.3892/mmr.2014.2974
127. Tong, J., Shen, Y., Zhang, Z., Hu, Y., Zhang, X., & Han, L. (2019). Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/snail signaling pathway. Bioscience Reports, 39(5), BSR20190452. https://doi.org/10.1042/BSR20190452
128. Tong, X., Mirzoeva, S., Veliceasa, D., Bridgeman, B. B., Fitchev, P., Cornwell, M. L., … Volpert, O. V. (2014). Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1. Oncotarget, 5(22), 11413–11427. https://doi.org/10.18632/oncotarget.2551
129. Tseng, T. H., Chien, M. H., Lin, W. L., Wen, Y. C., Chow, J. M., Chen, C. K., … Lee, W. J. (2017). Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21(WAF1/CIP1) expression. Environmental Toxicology, 32(2), 434–444. https://doi.org/10.1002/tox.22247
130. Turktekin, M., Konac, E., Onen, H. I., Alp, E., Yilmaz, A., & Menevse, S. (2011). Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29). Journal of Medicinal Food, 14(10), 1107–1117. https://doi.org/10.1089/jmf.2010.0208
131. Van Dross, R., Xue, Y., Knudson, A., & Pelling, J. C. (2003). The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines. The Journal of Nutrition, 133(11 Suppl 1), 3800s–3804s. https://doi.org/10.1093/jn/133.11.3800S
132. Wang, Q. R., Yao, X. Q., Wen, G., Fan, Q., Li, Y. J., Fu, X. Q., … Sun, X. G. (2011). Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression. Oncology Letters, 2(1), 43–47. https://doi.org/10.3892/ol.2010.215
133. Wang, W., VanAlstyne, P. C., Irons, K. A., Chen, S., Stewart, J. W., & Birt, D. F. (2004). Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. Nutrition and Cancer, 48(1), 106–114. https://doi.org/10.1207/s15327914nc4801_14
134. Wang, X., Wang, G., Li, X., Liu, J., Hong, T., Zhu, Q., … Ge, R. S. (2016). Suppression of rat and human androgen biosynthetic enzymes by apigenin: Possible use for the treatment of prostate cancer. Fitoterapia, 111, 66–72. https://doi.org/10.1016/j.fitote.2016.04.014
135. Wang, Y. C., & Huang, K. M. (2013). In vitro anti-inflammatory effect of apigenin in the helicobacter pylori-infected gastric adenocarcinoma cells. Food and Chemical Toxicology, 53, 376–383. https://doi.org/10.1016/j.fct.2012.12.018
136. Watjen, W., Weber, N., Lou, Y. J., Wang, Z. Q., Chovolou, Y., Kampkotter, A., … Proksch, P. (2007). Prenylation enhances cytotoxicity of apigenin and liquiritigenin in rat H4IIE hepatoma and C6 glioma cells. Food and Chemical Toxicology, 45(1), 119–124. https://doi.org/10.1016/j.fct.2006.08.008
137. Wong, I. L., Chan, K. F., Tsang, K. H., Lam, C. Y., Zhao, Y., Chan, T. H., & Chow, L. M. (2009). Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives. Journal of Medicinal Chemistry, 52(17), 5311–5322. https://doi.org/10.1021/jm900194w
138. Wu, D. G., Yu, P., Li, J. W., Jiang, P., Sun, J., Wang, H. Z., … Bie, P. (2014). Apigenin potentiates the growth inhibitory effects by IKK-beta-mediated NF-kappaB activation in pancreatic cancer cells. Toxicology Letters, 224(1), 157–164. https://doi.org/10.1016/j.toxlet.2013.10.007
139. Wu, K., Yuan, L. H., & Xia, W. (2005). Inhibitory effects of apigenin on the growth of gastric carcinoma SGC-7901 cells. World Journal of Gastroenterology, 11(29), 4461–4464. https://doi.org/10.3748/wjg.v11.i29.4461
140. Xu, M., Wang, S., Song, Y. U., Yao, J., Huang, K., & Zhu, X. (2016). Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/beta-catenin signaling pathway. Oncology Letters, 11(5), 3075–3080. https://doi.org/10.3892/ol.2016.4331
141. Xu, Y. Y., Wu, T. T., Zhou, S. H., Bao, Y. Y., Wang, Q. Y., Fan, J., & Huang, Y. P. (2014). Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: An in vitro study. International Journal of Clinical and Experimental Pathology, 7(7), 3938–3947.
142. Yi Lau, G. T., & Leung, L. K. (2010). The dietary flavonoid apigenin blocks phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in breast cell lines. Food and Chemical Toxicology, 48(10), 3022–3027. https://doi.org/10.1016/j.fct.2010.07.046
143. Zhang, L., Cheng, X., Gao, Y., Zheng, J., Xu, Q., Sun, Y., … Sun, Z. (2015). Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells. Food & Function, 6(11), 3464–3472. https://doi.org/10.1039/c5fo00671f
144. Zhao, M., Ma, J., Zhu, H. Y., Zhang, X. H., Du, Z. Y., Xu, Y. J., & Yu, X. D. (2011). Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90. Molecular Cancer, 10, 104. https://doi.org/10.1186/1476-4598-10-104
145. Zheng, P. W., Chiang, L. C., & Lin, C. C. (2005). Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sciences, 76(12), 1367–1379. https://doi.org/10.1016/j.lfs.2004.08.023
146. Zhong, Y., Krisanapun, C., Lee, S. H., Nualsanit, T., Sams, C., Peungvicha, P., & Baek, S. J. (2010). Molecular targets of apigenin in colorectal cancer cells: Involvement of p21, NAG-1 and p53. European Journal of Cancer, 46(18), 3365–3374. https://doi.org/10.1016/j.ejca.2010.07.007
147. Zhu, H., Jin, H., Pi, J., Bai, H., Yang, F., Wu, C., … Cai, J. (2016). Apigenin induced apoptosis in esophageal carcinoma cells by destruction membrane structures. Scanning, 38(4), 322–328. https://doi.org/10.1002/sca.21273
148. Zhu, Y., Mao, Y., Chen, H., Lin, Y., Hu, Z., Wu, J., … Xie, L. (2013). Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell International, 13(1), 54. https://doi.org/10.1186/1475-2867-13-54
149. Zhu, Y., Wu, J., Li, S., Wang, X., Liang, Z., Xu, X., … Xie, L. (2015). Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer. Molecular Medicine Reports, 11(2), 1004–1008. https://doi.org/10.3892/mmr.2014.2801